SCHEMBL285216

SCHEMBL285216

NC(Cc1ccc(Oc2ccc(O)cc2)cc1)C(=O)O

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 4/20 0.80
PCNA P12004 2/20 0.68
PTGS1 P23219 2/20 0.58
KDM4E B2RXH2 1/20 0.58
USP2 O75604 1/20 0.58
EGFR P00533 1/20 0.58
LCK P06239 1/20 0.58
FYN P06241 1/20 0.58
ADORA3 P0DMS8 1/20 0.58
ALOX15 P16050 1/20 0.58
HTR2A P28223 1/20 0.58
PTGS2 P35354 1/20 0.58
RECQL P46063 1/20 0.58
HIF1A Q16665 1/20 0.58
HSD17B10 Q99714 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
ALPI P09923 1/20 0.58
PKM P14618 1/20 0.58
XIAP P98170 1/20 0.58
PTPN1 P18031 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL285217 1.00 SLC7A5 (0.80) SLC7A5PCNAPTGS1KDM4EUSP2
SCHEMBL29556905 1.00 SLC7A5 (0.80) SLC7A5PCNAPTGS1KDM4EUSP2
SCHEMBL30622075 1.00 SLC7A5 (0.80) SLC7A5PCNAPTGS1KDM4EUSP2
Iodide SCHEMBL4670395 0.98 SLC7A5 (0.77) SLC7A5PCNAPTGS1KDM4EUSP2
SCHEMBL29455798 0.98 SLC7A5 (0.77) SLC7A5PCNAPTGS1KDM4EUSP2
SCHEMBL28173375 0.98 SLC7A5 (0.77) SLC7A5PCNAPTGS1KDM4EUSP2
Iodide SCHEMBL4672201 0.98 SLC7A5 (0.77) SLC7A5PCNAPTGS1KDM4EUSP2
2-Mercaptoethanol SCHEMBL27826214 0.91 SLC7A5 (0.67) SLC7A5PCNAPTGS1KDM4EUSP2
Tyrosine SCHEMBL1580 0.89 SLC7A5 (1.00) SLC7A5PCNAPTGS1KDM4EUSP2
Tyrosine SCHEMBL11676367 0.89 SLC7A5 (1.00) SLC7A5PCNAPTGS1KDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 288 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109387642-A A kind of detection reagent detecting trilute 河北艾驰生物科技有限公司 2019-02-26 CN claimed
CN-108463548-A Method for producing T cell from stem cell and immunotherapy method using the T cell 加利福尼亚大学董事会 2018-08-28 CN claimed
CN-108431209-A Derived and mature hepatocyte types of liver stem cells and uses thereof 新加坡科技研究局 2018-08-21 CN claimed
CN-104531607-B The primary bronchiole epithelial cell of dog and its application in immortalized cells is prepared 南京农业大学 2017-11-07 CN claimed
CN-107075469-A Mammal limbal stem cell, its production method and its purposes of culture 加利福尼亚大学董事会 2017-08-18 CN claimed
CN-106456672-A Functional oligodendrocytes derived from pluripotent stem cells and methods of making and using the same 纽约干细胞基金会有限公司 2017-02-22 CN claimed
US-20100075435-A1 BIOTINYLATED THYROXINE FUJIFILM CORPORATION (JP) 2010-03-25 US claimed
CN-1218755-C Stem cell regenerating surface cornea and its application in corneal transplantation KEYU UNION STEM CELL BIOTECHNO (CN) 2005-09-14 CN claimed
US-20040234592-A1 Mixture containing thyroid hormone , ethanolamine and emulsifier KARO BIO AB (SE) 2004-11-25 US claimed
EP-1404413-A2 DERMATOLOGICAL FORMULATIONS KARO BIO AB (SE) 2004-04-07 EP claimed
WO-2002089917-A2 DERMATOLOGICAL FORMULATIONS KARO BIO AB (SE) 2002-11-14 WO claimed
US-20020123521-A1 Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds KOO, CATHERINE, DR 2002-09-05 US claimed
US-6380255-B1 TOPICALLY APPLYING TO SKIN THYROID HORMONE COMPOUND TOGETHER WITH A BASE FOR THERAPY OF SKIN ATROPHY KARO BIO AB (SE) 2002-04-30 US claimed
WO-2002005834-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE AGONIST COMPOUNDS FOR TREATING DERMIS CONDITIONS KARO BIO AB (SE) 2002-01-24 WO claimed
US-6221911-B1 REDUCING SUBCUTANEOUS FAT DEPOSITS IN A SUBJECT; IMPROVING THE SKIN CONDITION OF A SUBJECT KARO BIO AB (SE) 2001-04-24 US claimed
EP-0831769-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS KARO BIO AB (SE) 1998-04-01 EP claimed
US-5658885-A OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-19 US claimed
WO-1996040048-A9 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS 1997-03-27 WO claimed
WO-1996040048-A2 NOVEL USES FOR THYROID HORMONES OR THYROID HORMONE-LIKE COMPOUNDS KARO BIO AB (SE) 1996-12-19 WO claimed
US-4299812-A Immunoassay of thyroxine in neonates using dried blood samples DIAGNOSTIC PRODUCTS CORP. (US) 1981-11-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075435-A1 BIOTINYLATED THYROXINE TPO, TSHR, THRB SLC7A5 67/4885PCNA 3006/4885PTGS1 4539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.